GW Pharmaceuticals says Epidiolex would cost $32,500 each year

GW Pharmaceuticals says Epidiolex would cost $32,500 each year

GW Pharmaceuticals has revealed the expense of Epidiolex, the initial cannabis-based medication which has been authorized by the United States Food and Drug management. Based on the medication manufacturer, Epidiolex would price each patient on average $32,000 each year.

British-based GW Pharmaceuticals made the revelation for a call with investors week that is last.

Treatment plan for unusual type of epilepsy

Epidiolex was created as treatment plan for what is cbd oil two uncommon types of childhood epilepsy: Dravet problem and Lennox-Gastaut problem. Both of these medical conditions are described as regular and hard-to-treat seizures.(więcej…)